| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 16.297 | 18.927 | 31.177 | 30.085 | 29.088 | 25.636 | 26.877 | 24.858 |
| Total Income - EUR | - | - | 16.297 | 18.927 | 31.177 | 30.085 | 29.088 | 25.636 | 26.878 | 25.562 |
| Total Expenses - EUR | - | - | 3.783 | 634 | 5.109 | 8.329 | 9.261 | 8.190 | 10.647 | 3.906 |
| Gross Profit/Loss - EUR | - | - | 12.514 | 18.293 | 26.068 | 21.756 | 19.826 | 17.446 | 16.231 | 21.656 |
| Net Profit/Loss - EUR | - | - | 12.204 | 18.104 | 25.756 | 21.455 | 19.562 | 17.190 | 15.962 | 18.538 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Theopatexp Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 13.018 | 30.762 | 36.128 | 36.556 | 94.081 | 110.006 | 125.144 | 121.838 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.868 | 2.450 | 0 | 0 | 42.741 | 48.916 | 65.304 | 111.029 |
| Cash | - | - | 10.150 | 28.312 | 36.128 | 36.556 | 51.340 | 61.090 | 59.840 | 10.809 |
| Shareholders Funds | - | - | 12.248 | 30.127 | 36.128 | 36.556 | 93.292 | 91.148 | 103.801 | 121.759 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 771 | 635 | 0 | 0 | 790 | 18.858 | 21.343 | 79 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Theopatexp Srl